ECAP-Based Stimulation Control for Neural Implants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medical devices for electrical stimulation therapy struggle to automatically adjust stimulation parameters in response to changes in the distance between electrodes and target tissues due to patient movement or lead migration, leading to transient overstimulation or reduced therapeutic efficacy.

Innovation Solution

A system and method that utilize evoked compound action potentials (ECAPs) sensed by a medical device to adjust the intensity of electrical stimulation pulses. The system includes a computing device running a therapy-management application that interfaces with the medical device to reduce stimulation intensity when an ECAP exceeds a 'reaction' threshold and increase intensity when an ECAP drops below a 'recovery' threshold, with user-modifiable threshold values through a graphical user interface.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If electrical stimulation intensity is increased to maintain therapeutic efficacy, then treatment effectiveness is improved, but risk of transient overstimulation increases

Engineering Contradiction:
Improvetherapeutic efficacyVSAvoidtransient overstimulation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system continuously monitors ECAP amplitudes and uses this feedback to dynamically adjust stimulation intensity. When ECAP amplitude exceeds a threshold indicating reduced electrode-tissue distance, the system automatically reduces stimulation intensity to prevent overstimulation. This closed-loop feedback mechanism resolves the contradiction by enabling adaptive control that maintains therapeutic efficacy while preventing harmful overstimulation.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The stimulation intensity is made dynamic rather than fixed, allowing real-time adjustment based on changing electrode-tissue distance. The system transitions from static parameter delivery to dynamic parameter modulation responsive to physiological feedback, enabling the therapy to adapt to patient movement and lead migration while maintaining optimal therapeutic effect.

Inventive Principle:
Principle #15Dynamics

2Ease of operation

If electrical stimulation parameters are kept constant to simplify device operation, then ease of operation is improved, but adaptability to patient movement and lead migration deteriorates

Engineering Contradiction:
Improvedevice operation simplicityVSAvoidresponse to patient movement
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The system performs self-adjustment of stimulation parameters based on automatic ECAP monitoring and analysis. The device autonomously detects changes in electrode-tissue distance and modifies stimulation intensity without requiring manual intervention from the patient or clinician. This self-service capability maintains ease of operation while achieving high adaptability to physiological changes.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system implements dynamic parameter adjustment that automatically adapts to changing physiological conditions. Rather than requiring manual reprogramming, the device continuously monitors ECAP signals and dynamically modifies stimulation parameters in response to patient movement, lead migration, or tissue remodeling, thereby maintaining both simplicity and adaptability.

Inventive Principle:
Principle #15Dynamics

3Adaptability or versatility

If ECAP monitoring is implemented to enable automatic stimulation adjustment, then adaptability is improved, but device complexity increases

Engineering Contradiction:
Improveautomatic parameter adjustmentVSAvoidsystem architecture
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system uses existing ECAP sensing capability for multiple purposes: initial therapy programming, ongoing adaptivity, and automatic parameter adjustment. By making the ECAP monitoring function multi-purpose, the patent avoids adding separate sensing systems and reduces overall device complexity while achieving high adaptability through intelligent use of existing hardware.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system implements a feedback loop that uses ECAP amplitude measurements to automatically control stimulation parameters. This feedback mechanism enables the device to self-regulate based on physiological response, reducing the need for complex external monitoring equipment and simplifying the overall system architecture while maintaining high adaptability.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively prevents transient overstimulation by dynamically adjusting stimulation parameters based on real-time ECAP feedback, ensuring consistent therapeutic efficacy and patient comfort.

Implementation Method 1

An evoked compound action potential (ECAP) is synchronous firing of a population of neurons which occurs in response to the application of a stimulus including, in some cases, an electrical stimulus by a medical device.

Methodology Applied
Scientific EffectEvoked compound action potential:

Implementation Method 2

Electrical stimulation may be delivered to a patient by the medical device in a train of electrical pulses, and parameters of the electrical pulses may include a frequency, an amplitude, a pulse width, and a pulse shape.

Methodology Applied
Scientific EffectElectrical stimulation:

Data Source

PatentEP4183444B1Therapy programming based on evoked compound action potentials
Publication Date: 2025.01.29 MEDTRONIC INC
  • EP4183444B1 patent drawingFigure 1
  • EP4183444B1 patent drawingFigure 2
  • EP4183444B1 patent drawingFigure 3

AI summary

This disclosure is directed to devices, systems, and techniques for controlling electrical stimulation. In some examples, a computing device includes a therapy-management application configured to assist a user to: capture a representative evoked compound action potential (ECAP) signal from a patient based; apply one or more filters to the representative ECAP signal to select one or more parameters of the representative ECAP signal; and control electrical stimulation therapy based at least in part on the one or more parameters.